Literature DB >> 21838211

Two polymorphisms of RCAN1 gene associated with Alzheimer's disease in the Chinese Han population.

K G Lin1, M Tang, Y B Guo, H Y Han, Y H Lin.   

Abstract

OBJECTIVE: Regulator of calcineurin 1 (RCAN1) gene is a regulator on the activity of calcineurin and was reported to be overexpressed in Alzheimer's disease. The aim of this study was to evaluate several polymorphisms of RCAN1, located in the probable promoter region of RCAN1-4 and around the exonic splicing enhancer motifs of RCAN1, in a cohort of Chinese late-onset Alzheimer's disease.
METHODS: A pilot case-control study was conducted in 142 Alzheimer's disease patients and 99 nondemented controls from Chinese Han population. Fragments of the RCAN1 including 5 polymorphisms (rs71324311, rs3831376, rs10550296, rs8135540, rs78899361) were amplified and sequenced.
RESULTS: In our sample, 2 polymorphisms (rs71324311 and rs10550296) were associated with Alzheimer's disease. Of these 2 polymorphisms, the heterozygous deletion genotype of rs71324311 was more prevalent in non-demented controls than in those with Alzheimer's disease (4% vs. 0%), indicating a slight protective role (Fisher's exact test, p = 0.03; crude odds ratio = 0.96, 95% confidence interval = 0.92-0.99). There was only a trend towards a significant difference in the distributions of genotypes of rs10550296 between 2 groups (chi2 = 1.93; p = 0.17; crude odds ratio = 1.44, 95% confidence interval = 0.85-2.41). However, logistic regression analysis showed that the age-, gender- and apolipoprotein E epsilon4-adjusted odds ratio of Alzheimer's disease with rs10550296 heterozygous deletion genotype was 2.11 (chi2 = 4.42; p = 0.04; 95% confidence interval = 1.05-4.20).
CONCLUSIONS: Regarding Alzheimer's disease susceptibility in Chinese Han population, our data suggested a protective role for the rs71324311 heterozygous deletion genotype and a risk role from the rs10550296 heterozygous deletion genotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838211

Source DB:  PubMed          Journal:  East Asian Arch Psychiatry        ISSN: 2078-9947


  7 in total

Review 1.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

2.  RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer's disease, and normative aging.

Authors:  Helen Wong; Jordan M Buck; Curtis Borski; Jessica T Pafford; Bailey N Keller; Ryan A Milstead; Jessica L Hanson; Jerry A Stitzel; Charles A Hoeffer
Journal:  J Neurodev Disord       Date:  2022-05-24       Impact factor: 4.074

Review 3.  Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review.

Authors:  Erwin Lemche
Journal:  Curr Genomics       Date:  2018-11       Impact factor: 2.236

4.  Mining disease genes using integrated protein-protein interaction and gene-gene co-regulation information.

Authors:  Jin Li; Limei Wang; Maozu Guo; Ruijie Zhang; Qiguo Dai; Xiaoyan Liu; Chunyu Wang; Zhixia Teng; Ping Xuan; Mingming Zhang
Journal:  FEBS Open Bio       Date:  2015-03-27       Impact factor: 2.693

Review 5.  The importance of understanding individual differences in Down syndrome.

Authors:  Annette Karmiloff-Smith; Tamara Al-Janabi; Hana D'Souza; Jurgen Groet; Esha Massand; Kin Mok; Carla Startin; Elizabeth Fisher; John Hardy; Dean Nizetic; Victor Tybulewicz; Andre Strydom
Journal:  F1000Res       Date:  2016-03-23

6.  Association Between DSCR1 Variations and Congenital Heart Disease Susceptibility.

Authors:  Ren Yu Guo; Xiao Feng Li; Song Bai; Jian Guo; Nan Ding; Zhong Zhi Li
Journal:  Med Sci Monit       Date:  2015-11-16

7.  RCAN1 in the inverse association between Alzheimer's disease and cancer.

Authors:  Qiang Fu; Yili Wu
Journal:  Oncotarget       Date:  2017-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.